学会発表(国際)

Shiroiwa T, Fukuda T, Shimozuma K, Mouri M, Hagiwara Y, Kawahara T, Ohsumi S, Hozumi Y, Sagara Y, Ohashi Y, Mukai H. Cost-effectiveness of first-line S-1 therapy for metastatic breast cancer patients compared with taxanes: an analysis based on the randomized phase III SELECT BC trial. International Society for Pharmacoeconomics and Outcome Research 19th Annual European Congress, Vienna, Austria, November 2. Abstract PCN161.

Shiroiwa T, Fukuda T, Shimozuma K, Mouri M, Hagiwara Y, Kawahara T, Ohsumi S, Hozumi Y, Sagara Y, Ohashi Y, Mukai H. Cost-effectiveness of first-line S-1 therapy for metastatic breast cancer patients compared with taxanes: an analysis based on the randomized phase III SELECT BC trial. International Society for Pharmacoeconomics and Outcome Research 19th Annual European Congress, Vienna, Austria, November 2. Abstract PCN161.

International Society for Pharmacoeconomics and Outcome Research 19th Annual European Congress, Vienna, Austria, November 2. Abstract PCN204.

TOP